The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of urinary comprehensive genomic profile with risk of recurrence of BCG-unresponsive non-muscle invasive bladder cancer treated with atezolizumab in SWOG S1605.
 
Marie-Pier St-Laurent
Honoraria - Bayer
 
Melissa Plets
No Relationships to Disclose
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Biosyent; Bristol-Myers Squibb; EMD Serono; Ferring; Janssen Oncology; Merck; Minogue Medical; miR Scientific; Nonagen Bioscience; Pfizer; Prokarium; Protara Therapeutics; Protara Therapeutics; QED Therapeutics; Roche Canada; Sanofi; Sesen Bio; STIMIT; TerSera; Tolmar; Urogen pharma; Verity Pharmaceuticals
Speakers' Bureau - Bayer; BioSyent; Pfizer; TerSera
Research Funding - iProgen
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
 
Parminder Singh
Honoraria - Curio Science; Medpage/ASCO
Consulting or Advisory Role - AVEO; Bayer; EMD Serono; ImmunityBio; Janssen Oncology; Seattle Genetics/Astellas (Inst)
Research Funding - EMD Serono (Inst)
(OPTIONAL) Uncompensated Relationships - Seagen
 
David James McConkey
Honoraria - H3 Biomedicine; Janssen Oncology
 
Scott Lucia
Stock and Other Ownership Interests - 3D Biopsy
 
Vadim S Koshkin
Consulting or Advisory Role - Clovis Oncology; Gerson Lehrman Group; Guidepoint Global; Janssen; Pfizer/EMD Serono; Seattle Genetics/Astellas
Research Funding - Clovis Oncology; Endocyte (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Seagen (Inst); Taiho Oncology (Inst)
 
Kelly Lynn Stratton
Honoraria - Bayer; Dendreon (Inst); Janssen; Johnson & Johnson/Janssen; Merck; MJH Life Sciences; Oakstone Publishing; Oakstone Publishing (Inst); Sun Pharma; Urology times
Consulting or Advisory Role - AMRO Pharma (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Dendreon (Inst); Ebix (Inst); Elsevier (Inst); Janssen (Inst); Large Urology Group Practice Association (Inst); Merck (Inst); Myriad Genetics (Inst); Sanofi (Inst)
Speakers' Bureau - Arkansas Urology; Bayer; Bayer Speaker Bureau
Research Funding - Advantage Pharmaceuticals (Inst); Alliance Foundation Trials (Inst); Anchiano (Inst); Astellas ENACT CTA (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Dendreon (Inst); EMD Serono (Inst); EMD Serono (Inst); Ferring (Inst); Genentech (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Myriad Genetics (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Roche/Genentech (Inst); RTOG (Inst); TARIS Biomedical (Inst); TARIS Biomedical (Inst)
Travel, Accommodations, Expenses - Dendreon; Dendreon (Inst); Myriad Genetics
 
Trinity Bivalacqua
Honoraria - Ferring; Janssen; UROGENE
 
Wassim Kassouf
Consulting or Advisory Role - BMS; Ferring; Janssen; Merck; Pfizer/EMD Serono; Photocure; Roche; Seagen; Sesen Bio
Research Funding - Sesen Bio (Inst)
 
Sima P. Porten
Honoraria - American Urologic Association; Exact Sciences; Pacific Edge
Consulting or Advisory Role - AstraZeneca; Oncuria; Photocure; Stryker
Research Funding - Photocure (Inst)
 
Rick Bangs
Consulting or Advisory Role - Nonagen Bioscience
Other Relationship - Bladder Cancer Advocacy Network; National Cancer Institute; SWOG; SWOG; SWOG
(OPTIONAL) Uncompensated Relationships - Genentech; Gilead Sciences
 
Catherine Tangen
No Relationships to Disclose
 
Ian M. Thompson
Leadership - H-E-B (grocery store chain)
Consulting or Advisory Role - Magforce
Research Funding - MagForce
Patents, Royalties, Other Intellectual Property - I have several patents with colleagues involving novel biomarkers for cancer and two devices for sexual dysfunction and urinary incontinence. No revenues at this time and our University IP office is working with industry to determine if these can be comme
 
Joshua J Meeks
Honoraria - Astellas Pharma; AstraZeneca; Imvax; incyte; Janssen; Merck; Pfizer; Prokarium; Urogen pharma
Research Funding - Epizyme; Merck Sharp & Dohme
Patents, Royalties, Other Intellectual Property - NMIBC genetic classifier (Inst); TCGA Classifier (Inst)
Other Relationship - Olympus
 
Vincent M. Caruso
Employment - Convergent Genomics
Stock and Other Ownership Interests - Convergent Genomics
 
Kevin G. Phillips
Employment - Convergent Genomics
Stock and Other Ownership Interests - Convergent Genomics
Research Funding - Convergent Genomics
Patents, Royalties, Other Intellectual Property - Patents pertaining to proprietary DNA sequencing and disease classification at Convergent Genomics.
Travel, Accommodations, Expenses - Convergent Genomics
 
Vincent T. Bicocca
Employment - Convergent Genomics, Inc.
Stock and Other Ownership Interests - Convergent Genomics, Inc.
Research Funding - Convergent Genomics, Inc.
Patents, Royalties, Other Intellectual Property - Convergent Genomics, Inc.
 
Trevor G. Levin
Employment - Convergent Genomics
Leadership - Convergent Genomics
Stock and Other Ownership Interests - Convergent Genomics
Research Funding - Convergent Genomics
Patents, Royalties, Other Intellectual Property - Inventor on patents filed by Convergent Genomics
 
Seth P. Lerner
Stock and Other Ownership Interests - Aura Biosciences; C2i genomics
Honoraria - Grand Rounds in Urology; UroToday
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; Bristol-Myers Squibb Foundation/Janssen; C2i Genomics; Ferring; Pfizer/EMD Serono; Protara Therapeutics; Stimit; Vaxiion; Verity Pharmaceuticals
Research Funding - Endo Pharmaceuticals; FKD Therapies; Japan BCG Laboratory; QED Therapeutics; Roche/Genentech; Vaxiion; Viventia Biotech
Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier
Other Relationship - Bladder Cancer Journal; UpToDate